ClinicalTrials.gg
Drug

Venetoclax clinical trials

Also written Venclexta, ABT-199, GDC-0199 and Venclyxto.

studies test it
486
open now
222
in phase 3
53
first study started
2010

How each study uses venetoclax is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the venetoclax studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
11 Apr 2016 · VENCLEXTA · NDA 208573 (FDA, Drugs@FDA)
European Union
4 Dec 2016 · Venclyxto · EMEA/H/C/004106 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Venetoclax
390
Venetoclax Oral Tablet
6
Venetoclax (VEN)
5
Venclextra®
3
Ven
3

Brand

Venclexta
166

Development codes

ABT-199
154
GDC-0199
114
RG7601
76
ABT-0199
74
RO5537382
5

Other names

Venclyxto
87

In one entry with another drug

Given together, or one or the other

CACAG+VEN
4
Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
3
Venetoclax, Azacitidine
2

Studies by the year they started

482 studies that test it; most in 2024 (63); 4 more planned to start later

Studies that test venetoclax, by start year
YearStudies
20101
20111
20126
20135
201412
20156
201610
201727
201835
201936
202040
202134
202259
202346
202463
202551
202650

Who runs them

Industry 83 · Other 403

AbbVie (50) · M.D. Anderson Cancer Center (47) · National Cancer Institute (NCI) (28) · Institute of Hematology & Blood Diseases Hospital, China (24) · The First Affiliated Hospital of Soochow University (23) · Dana-Farber Cancer Institute (12) · City of Hope Medical Center (11) · Hoffmann-La Roche (10)

Often tested with

Tested in the same studies.

Azacitidine (111) · Cytarabine (45) · Obinutuzumab (38) · Decitabine (31) · Ibrutinib (28) · Rituximab (26) · Dexamethasone (21) · Acalabrutinib (15)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 8 phase 3 studies under way

Venetoclax is the comparator. A study of two new drugs counts under both.

  • 3Sonrotoclax · BeOne Medicines · next primary completion Sep 2029
  • 2Zanubrutinib · BeOne Medicines · next primary completion Feb 2031
  • 2Rituximab · BeOne Medicines, Ruijin Hospital · next primary completion Jul 2027
  • 1Atezolizumab · Hoffmann-La Roche · next primary completion Jul 2028
  • 1Niraparib · Hoffmann-La Roche · next primary completion Jul 2028
  • 1Cabozantinib · Hoffmann-La Roche · next primary completion Jul 2028
  • 1Galinpepimut-s · Sellas Life Sciences Group
  • 1Tacabrutideg · BeOne Medicines · next primary completion May 2028
Reaching primary completion within a year · 87, 8 in phase 3

Studies that test venetoclax, phase 3 first.

Studies

Open first, then newest update. How each study uses venetoclax is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 486

See all 486 studies that test venetoclax →

Given beside what is tested · 186 — venetoclax is usual care or a partner of the new treatment

Showing 20 of 186.

As the comparator · 12 — what is tested is compared with venetoclax

Codes

What other systems call venetoclax · ClinicalTrials.gg INT006262

  • MeSH (NLM) C579720venetoclaxConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) N54AIC43PWVENETOCLAXConfirmed FDA, NLM, Wikidata
  • RxNorm 1747556Confirmed FDA, Wikidata
  • Wikidata Q23671272venetoclaxConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C103147VenetoclaxOne source FDA
  • DrugBank DB11581One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.